Hydrazine hydrate (1:1) → 3-Cyclobutyl-7-([5-(1H-pyrazol-5-yl)-2-pyridinyl]oxy}-2,3,4,5-tetrahydro-1H-3-benzazepine
反応式
[CH:1]1([N:5]2[CH2:11][CH2:10][C:9]3[CH:12]=[CH:13][C:14]([O:16][C:17]4[N:22]=[CH:21][C:20]([C:23](=O)/[CH:24]=[CH:25]/[N:26](C)C)=[CH:19][CH:18]=4)=[CH:15][C:8]=3[CH2:7][CH2:6]2)[CH2:4][CH2:3][CH2:2]1.O.[NH2:31]N>CO>[CH:1]1([N:5]2[CH2:11][CH2:10][C:9]3[CH:12]=[CH:13][C:14]([O:16][C:17]4[CH:18]=[CH:19][C:20]([C:23]5[NH:31][N:26]=[CH:25][CH:24]=5)=[CH:21][N:22]=4)=[CH:15][C:8]=3[CH2:7][CH2:6]2)[CH2:2][CH2:3][CH2:4]1参加物
4
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
A mixture of (2E)-1-{6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3-pyridinyl}-3-(dimethylamino)-2-propen-1-one (D53) (195 mg, 0.5 mmol) and hydrazine hydrate (0.4 ml) in methanol (3 ml) was heated at reflux for 24 hours. The reaction mixture was cooled and applied to a SCX ion exchange cartridge (Varian bond-elute, 10 g) and washed with methanol and then a mixture of 0.880 ammonia/methanol (1:9). The combined basic fractions were concentrated in vacuo and the resulting residue purified by column chromatography eluting with a mixture of 0.880 ammonia:methanol:dichloromethane (1:9:90) to afford the title compound (E215). MS (ES+) m/e 361 [M+H]+.
後処理
- temperaturewas heated
- temperatureat reflux for 24 hours
- temperatureThe reaction mixture was cooled
- washwashed with methanol
- additiona mixture of 0.880 ammonia/methanol (1:9)
- concentrationThe combined basic fractions were concentrated in vacuo
- customthe resulting residue purified by column chromatography
- washeluting with a mixture of 0.880 ammonia:methanol:dichloromethane (1:9:90)
出典と根拠
- ORDレコード
- ord-7051313a9c074d679a4cadf669c1f102
- 出典データセット
- uspto-grants-2010_09
- 特許番号
- US07799773B2
反応ノート
読み込み中…